On the upside
Pluristem Therapeutics (Nasdaq: PSTI) reported the successful treatment of a lymphoma patient using the company's Placental eXpanded cells drug delivery platform.
Cognizant Technology Solutions (Nasdaq: CTSH) reported higher second quarter earnings that topped analyst estimates as revenue rose and lifted its full year guidance.
On the downside
Knight Capital (NYSE: KCG) announced plans to sell $400 million worth of convertible stock. Publicis denied rumors that it held acquisition talks with Interpublic Group (NYSE: IPG).
Exelixis (Nasdaq: EXEL) will offer 20 million shares of common stock and $225 million worth of convertible senior notes.
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The Russell 2000 which tracks small cap stocks climbed 7 points to 796.